Injection Port Market Witnesses High Growth Due to Rising Demand in Pharmaceutical Industry
Injection
port, also known as injection site or injection septum, is a small plate or a
rubber stopper filled with silicone that allows easy access for syringes to
draw liquids into or inject liquids out of intravenous or intradermal lines
without needing to disconnect medical tubing. Injection ports permit repeated
access to IV lines and catheters. The global injection port market is estimated
to be valued at US$ 1.57 Bn in 2024 and is expected to exhibit a CAGR of 7.6%
over the forecast period 2024 to 2030.
The injection port market is driven by the growing pharmaceutical industry
globally. Injection ports find widespread application in pharmaceutical drug
manufacturing and drug delivery processes for easy filling, transfer and
withdrawing of fluids at various stages. They help increase efficiency and
productivity while reducing human error and risk of contamination in comparison
to conventional methods. The Single-Use Injection Ports are widely gaining
popularity as they eliminate the cleaning and sterilization steps required for
multi-use injection ports.
Key Takeaways
Key
players operating in the injection port market are Jungbunzlauer, Gadot
Biochemical Industries, Sucroal, Dr. Paul Lohmann, Global Calcium, TATE &
LYLE, American Elements, Triveni Chemicals, A.B. Enterprises, Nikunj Chemicals,
Advait Industries, Anmol Chemicals, Krishna Chemicals, AMS biotechnology, Henan
Honghui Biotechnology.
The key opportunities in the market include rising demand for prefilled
syringes and injectable drug delivery systems from the biopharmaceutical
industry. Growing preference for self-administered injection devices and
disposable medical devices also presents significant growth prospects.
North America currently dominates the global injection port market followed by
Europe and Asia Pacific. However, Asia Pacific is expected to witness highest
growth owing to growing pharmaceutical manufacturing in countries like China,
India and Japan and increasing healthcare spending. Key players are expanding
their manufacturing and distribution footprint in emerging economies of Asia
Pacific and Latin America to tap into new revenue streams.
Market Drivers
-
Increasing demand for efficient drug delivery devices from pharmaceutical
manufacturers to streamline production processes.
- Rising prevalence of chronic diseases and growing geriatric population
requiring injection-based drug therapies.
Market Restraints
-
Availability of alternative products like prefilled syringes, vials and
ampoules limits the demand for injection ports to some extent.
- Concerns regarding leachable and extractable of silicone and other materials
used in injection ports hampers their adoption.
Segment
Analysis
The injection port market is dominated by the plastic segment. The plastic
injection ports account for over 60% of the total market share owing to their
lightweight and relatively cheaper price as compared to other materials such as
glass and metal. Plastic ports are used in large volumes in pharmaceutical and
food & beverage applications. The high durability and leak-proof nature of
plastic ports have increased their preference among manufacturers in these
industries.
The pharmaceutical segment holds the largest share of over 30% of the total
injection port market. Injection ports are predominantly used for filling
liquid pharmaceutical drugs in vials and ampoules. Their non-reactive and
sterilizable properties assure contamination-free drug filling. The expansion
of the pharmaceutical industry and growing demand for portable injections are
expected to drive the demand for injection ports from this segment.
Global Analysis
On the basis of region, the Asia Pacific region dominates the global injection
port market and is expected to maintain its leading position during the
forecast period. China and India are the top contributors to the regional
market growth. Both countries have established themselves as major
pharmaceutical manufacturing hubs. The availability of generic drugs at
competitive prices has boosted pharmaceutical production in these nations.
This, in turn, has augmented the demand for injection ports for manufacturing
operations.
North America stands as the second largest market for injection ports
stimulated by robust pharmaceutical and food industries in the United States.
Strong support from government organizations to promote medical research and
drug development programs in the US augurs well for the regional market.
Comments
Post a Comment